- In February 2025, bioMérieux announced that its BIOFIRE FILMARRAY Gastrointestinal (GI) Panel Mid obtained clearance from the U.S. Food and Drug Administration (FDA). This midplex molecular panel tests for 11 common bacteria, viruses, and parasites associated with gastroenteritis from a single sample, with results available in approximately one hour. This launch expands their portfolio of syndromic testing for gastrointestinal infections
- In September 2024, Roche launched the cobas Respiratory flex test, the first to use Roche's novel and proprietary TAGS (Temperature-Activated Generation of Signal) technology. This breakthrough technology enables the high-throughput, simultaneous detection of up to 12 common respiratory viruses in a single patient sample, enhancing diagnostic capabilities on their cobas 5800, 6800, and 8800 molecular diagnostic analyzers
- In April 2024, Bio-Rad Laboratories, Inc. announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. While primarily for clinical research in oncology, this highlights Bio-Rad's advancement in multiplexing capabilities within diagnostics, capable of simultaneous detection of multiple mutations in a single well with high sensitivity
- In January 2024, QIAGEN announced the launch of new QIAstat-Dx syndromic testing panels in India, including the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel. These new panels join their existing Respiratory SARS-CoV-2 Panel, further expanding QIAGEN's comprehensive syndromic testing menu for rapid and accurate diagnosis of infectious diseases in the region
- In November 2022, Cepheid launched its Xpert Xpress MVP (Multiplex Vaginal Panel) to support more accurate women's health diagnosis in the U.S. This FDA-cleared multiplexed PCR test detects DNA from organisms associated with three distinct conditions – bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis – from a single sample within approximately 60 minutes, aiding in more precise diagnosis and targeted treatment
